Hogy Medical Co. Ltd. reported consolidated and non-consolidated earnings results for the year ended March 31, 2016. For the year, on consolidated basis, the company reported net sales of JPY 36,568 million against JPY 35,233 million a year ago. Operating income was JPY 8,784 million against JPY 8,505 million a year ago. Ordinary income was JPY 8,924 million against JPY 8,768 million a year ago. Profit attributable to owners of parent was JPY 5,910 million or JPY 375.81 per share compared to JPY 5,659 million or JPY 359.81 per share for the same period a year ago. Income before income taxes was JPY 8,743 million compared to JPY 8,678 million a year ago. Net cash provided by operating activities was JPY 6,809 million compared to JPY 7,935 million a year ago. Purchase of tangible fixed assets was JPY 14,690 million compared to JPY 10,525 million a year ago. Purchase of intangible fixed assets was JPY 1,094 million compared to JPY 1,266 million a year ago.

For the year, on non-consolidated basis, the company reported total net sales of JPY 36,320 million against JPY 34,985 million a year ago. Operating income was JPY 7,729 million against JPY 7,651 million a year ago. Ordinary income was JPY 7,997 million against JPY 8,030 million a year ago. Net income was JPY 5,249 million or JPY 333.74 per share compared to JPY 5,142 million or JPY 326.95 per share for the same period a year ago. Income before income taxes was JPY 7,814 million compared to JPY 7,939 million a year ago.

The company provided consolidated and non-consolidated earnings guidance for the first six months of fiscal year 2017 and year ending March 31, 2017. For the six months, on consolidated basis, expects net sales of JPY 18,490 million, operating income of JPY 3,570 million, ordinary income of JPY 3,650 million and net income of JPY 2,520 million or JPY 160.22 per share.

For the year, on consolidated basis expects net sales of JPY 38,400 million, operating income of JPY 7,180 million, ordinary income of JPY 7,280 million and net income of JPY 5,000 million or JPY 317.90 per share.

For the six months, on non-consolidated basis, expects net sales of JPY 18,350 million, operating income of JPY 3,040 million, ordinary income of JPY 3,120 million and net income of JPY 2,140 million or JPY 136.06 per share.

For the year, on non-consolidated basis expects net sales of JPY 38,110 million, operating income of JPY 6,320 million, ordinary income of JPY 6,510 million and net income of JPY 4,460 million or JPY 283.56 per share.